I-124-CLR1404: Phase I/II started

Novelos began an open-label, U.S. Phase I/II trial to evaluate I-124-CLR1404 (LIGHT) in PET imaging in about 81 patients with advanced solid tumors, including soft tissue sarcoma and triple-negative b...